Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy

Esther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, Joanna H. Shih, Stephanie A. Harmon, Ilhan Lim, Frank Lin, Stephen Adler, Philip Eclarinal, Yolanda L. McKinney, Deborah Citrin, William Dahut, Bradford J. Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Maria Merino, Peter Pinto, Janet F. Eary and Peter L. Choyke
Journal of Nuclear Medicine June 2020, 61 (6) 881-889; DOI: https://doi.org/10.2967/jnumed.119.234799
Esther Mena
1Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Liza Lindenberg
1Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ismail Baris Turkbey
1Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna H. Shih
2Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie A. Harmon
3Clinical Research Directorate, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilhan Lim
1Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Lin
1Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Adler
3Clinical Research Directorate, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Eclarinal
1Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yolanda L. McKinney
1Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah Citrin
4Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Dahut
5Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradford J. Wood
6Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Venkatesh Krishnasamy
6Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Chang
6Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elliot Levy
6Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Merino
7Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Pinto
8Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet F. Eary
9Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter L. Choyke
1Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 61 no. 6 881-889
DOI 
https://doi.org/10.2967/jnumed.119.234799
PubMed 
31676732

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication August 6, 2019
  • Accepted for publication October 7, 2019
  • Published online June 4, 2020.

Article Versions

  • previous version (November 1, 2019 - 13:36).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Esther Mena1,
  2. Maria Liza Lindenberg1,
  3. Ismail Baris Turkbey1,
  4. Joanna H. Shih2,
  5. Stephanie A. Harmon3,
  6. Ilhan Lim1,
  7. Frank Lin1,
  8. Stephen Adler3,
  9. Philip Eclarinal1,
  10. Yolanda L. McKinney1,
  11. Deborah Citrin4,
  12. William Dahut5,
  13. Bradford J. Wood6,
  14. Venkatesh Krishnasamy6,
  15. Richard Chang6,
  16. Elliot Levy6,
  17. Maria Merino7,
  18. Peter Pinto8,
  19. Janet F. Eary9 and
  20. Peter L. Choyke1
  1. 1Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  2. 2Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  3. 3Clinical Research Directorate, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  4. 4Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  5. 5Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  6. 6Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  7. 7Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  8. 8Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and
  9. 9Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  1. For correspondence or reprints contact: Esther Mena, Molecular Imaging Program, NCI, Building 10, B3B402, Bethesda, MD 20892. E-mail: esther.menagonzalez{at}nih.gov
View Full Text

Statistics from Altmetric.com

Cited By...

  • 47 Citations
  • 43 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
    Michael J. Morris, Steven P. Rowe, Michael A. Gorin, Lawrence Saperstein, Frédéric Pouliot, David Josephson, Jeffrey Y.C. Wong, Austin R. Pantel, Steve Y. Cho, Kenneth L. Gage, Morand Piert, Andrei Iagaru, Janet H. Pollard, Vivien Wong, Jessica Jensen, Tess Lin, Nancy Stambler, Peter R. Carroll, Barry A. Siegel
    Clinical Cancer Research 2021 27 13
  • Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
    Lauren Brady, Michelle Kriner, Ilsa Coleman, Colm Morrissey, Martine Roudier, Lawrence D. True, Roman Gulati, Stephen R. Plymate, Zoey Zhou, Brian Birditt, Rhonda Meredith, Gary Geiss, Margaret Hoang, Joseph Beechem, Peter S. Nelson
    Nature Communications 2021 12 1
  • Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions
    Nguyễn Thị Thanh Nhàn, Tohru Yamada, Kaori H. Yamada
    International Journal of Molecular Sciences 2023 24 16
  • The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
    Rang Wang, Guohua Shen, Mingxing Huang, Rong Tian
    Frontiers in Oncology 2021 11
  • Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non–Tumor-Related Uptake and Tumor Positivity
    Markus Kroenke, Lilit Mirzoyan, Thomas Horn, Jan C. Peeken, Alexander Wurzer, Hans-Jürgen Wester, Marcus Makowski, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher
    Journal of Nuclear Medicine 2021 62 8
  • Piflufolastat F 18: Diagnostic First Approval
    Susan J. Keam
    Molecular Diagnosis & Therapy 2021 25 5
  • PSMA Theranostics: Science and Practice
    Kgomotso Mokoala, Ismaheel Lawal, Thabo Lengana, Mankgopo Kgatle, Frederik L. Giesel, Mariza Vorster, Mike Sathekge
    Cancers 2021 13 15
  • Automatic segmentation of prostate cancer metastases in PSMA PET/CT images using deep neural networks with weighted batch-wise dice loss
    Yixi Xu, Ivan Klyuzhin, Sara Harsini, Anthony Ortiz, Shun Zhang, François Bénard, Rahul Dodhia, Carlos F. Uribe, Arman Rahmim, Juan Lavista Ferres
    Computers in Biology and Medicine 2023 158
  • 18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation
    Gary A. Ulaner, Beth Thomsen, Jeffrey Bassett, Robert Torrey, Craig Cox, Kevin Lin, Trushar Patel, Tust Techasith, Audrey Mauguen, Steven P. Rowe, Liza Lindenberg, Esther Mena, Peter Choyke, Jeffrey Yoshida
    Radiology 2022 305 2
  • Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting
    Andrea K. Miyahira, Kenneth J. Pienta, John W. Babich, Neil H. Bander, Jeremie Calais, Peter Choyke, Michael S. Hofman, Steven M. Larson, Frank I. Lin, Michael J. Morris, Martin G. Pomper, Shahneen Sandhu, Howard I. Scher, Scott T. Tagawa, Scott Williams, Howard R. Soule
    The Prostate 2020 80 15

Article usage

Article usage: November 2019 to April 2025

AbstractFullPdf
Nov 2019694094
Dec 2019129019
Jan 2020123026
Feb 2020129012
Mar 2020161023
Apr 2020105019
May 202068046
Jun 20208531377
Jul 20202371462
Aug 20201812165
Sep 20201571836
Oct 20201154234
Nov 2020702236
Dec 2020683936
Jan 2021373125
Feb 2021415243
Mar 2021384335
Apr 2021353521
May 2021376127
Jun 20212510633
Jul 2021216536
Aug 2021175937
Sep 2021176628
Oct 2021206451
Nov 2021276057
Dec 2021246231
Jan 2022377347
Feb 2022235031
Mar 2022217342
Apr 2022305743
May 2022194323
Jun 2022114730
Jul 202285135
Aug 2022144120
Sep 2022154225
Oct 2022103023
Nov 202272311
Dec 2022142517
Jan 2023153317
Feb 202394326
Mar 2023103920
Apr 2023161224
May 2023122921
Jun 202382510
Jul 2023112013
Aug 2023171618
Sep 2023132112
Oct 2023104614
Nov 202354216
Dec 2023131129
Jan 2024304016
Feb 2024143014
Mar 202441944
Apr 202457219
May 202426417
Jun 202493821
Jul 202474433
Aug 202484921
Sep 202425219
Oct 2024103219
Nov 202454216
Dec 202444810
Jan 202537217
Feb 20251012228
Mar 2025158024
Apr 20251111249
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (6)
Journal of Nuclear Medicine
Vol. 61, Issue 6
June 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
Esther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, Joanna H. Shih, Stephanie A. Harmon, Ilhan Lim, Frank Lin, Stephen Adler, Philip Eclarinal, Yolanda L. McKinney, Deborah Citrin, William Dahut, Bradford J. Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Maria Merino, Peter Pinto, Janet F. Eary, Peter L. Choyke
Journal of Nuclear Medicine Jun 2020, 61 (6) 881-889; DOI: 10.2967/jnumed.119.234799

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
Esther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, Joanna H. Shih, Stephanie A. Harmon, Ilhan Lim, Frank Lin, Stephen Adler, Philip Eclarinal, Yolanda L. McKinney, Deborah Citrin, William Dahut, Bradford J. Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Maria Merino, Peter Pinto, Janet F. Eary, Peter L. Choyke
Journal of Nuclear Medicine Jun 2020, 61 (6) 881-889; DOI: 10.2967/jnumed.119.234799
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Changes in Management After 18F-DCFPyL PSMA PET in Patients Undergoing Postprostatectomy Radiotherapy, with Early Biochemical Response Outcomes
  • Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
  • 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
  • 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
  • Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor Positivity
  • Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
  • Positive Predictive Value and Correct Detection Rate of 18F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard
  • Google Scholar

More in this TOC Section

Theranostics

  • Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
  • 177Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Show more Theranostics

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • prostate cancer
  • biochemical recurrence
  • PSMA
  • DCFPyL
  • PET
SNMMI

© 2025 SNMMI

Powered by HighWire